Intra-herb pharmacokinetics interaction between quercetin and isorhamentin

Acta Pharmacologica Sinica

Volumn 29, Issue 11, 2008, Pages 1376-1382

  Lan, Ke ^a   He, Jian Lin ^a   Tian, Yang ^a   Tan, Fei ^a   Jiang, Xue Hua ^a   Wang, Ling ^a   Ye, Li Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Absorption; Bioavailability; Caco 2 cell; Drug interaction; Flavone; P glycoprotein; Pharmacokinetic

Indexed keywords

BETA GLUCURONIDASE; BREAST CANCER RESISTANCE PROTEIN; COMPLEMENTARY DNA; GLYCOPROTEIN P; ISORHAMNETIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; QUERCETIN; SULFATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; GENETIC TRANSFECTION; HERB DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CELL LINE; CELL MEMBRANE PERMEABILITY; DOGS; DRUG INTERACTIONS; FLAVONOLS; HUMANS; MALE; P-GLYCOPROTEIN; QUERCETIN; RATS; RATS, WISTAR;

EID: 55149116576     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00884.x     Document Type: Article

References (38)

1. Aruna D, Naidu MU. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol 2007 63 : 333 8.
2. Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006 11 : 742 52.
3. Flanagan D. Understanding the grapefruit-drug interaction. Gen Dent 2005 53 : 282 5 quiz 286.
4. Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 2003 10 : 163 9.
5. Oh SM, Chung KH. Estrogenic activities of Ginkgo biloba extracts. Life Sci 2004 74 : 1325 35.
6. Hibasami H, Mitani A, Katsuzaki H, Imai K, Yoshioka K, Komiya T. Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells. Int J Mol Med 2005 15 : 805 9.
7. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C. Bioavailability of rutin and quercetin in rats. FEBS Lett 1997 409 : 12 16.
8. Ader P, Wessmann A, Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000 28 : 1056 67.
9. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975 9 : 229 34.
10. Cornish KM, Williamson G, Sanderson J. Quercetin metabolism in the lens: role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med 2002 33 : 63 70.
11. Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995 33 : 1061 80.
12. Limtrakul P, Khantamat O, Pintha K. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 2005 17 : 86 95.
13. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004 36 : 57 104.
14. Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 2006 78 : 2131 45.
15. Patel J, Buddha B, Dey S, Pal D, Mitra AK. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 2004 11 : 262 77.
16. Wang Y, Cao J, Zeng S. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 2005 57 : 751 8.
17. Fuller S, von Bonsdorff CH, Simons K. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 1984 38 : 65 77.
18. Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer 2000 83 : 366 74.
19. Hammerle SP, Rothen-Rutishauser B, Kramer SD, Gunthert M, Wunderli-Allenspach H. P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope. Eur J Pharm Sci 2000 12 : 69 77.
20. Lan K, Jiang X, He J. Quantitative determination of isorhamnetin, quercetin and kaempferol in rat plasma by liquid chromatography with electrospray ionization tandem mass spectrometry and its application to the pharmacokinetic study of isorhamnetin. Rapid Commun Mass Spectrom 2007 21 : 112 20.
21. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004 36 : 592 604.
22. Schulz HU, Schurer M, Bassler D, Weiser D. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. Arzneimittelforschung 2005 55 : 561 8.
23. Schulz HU, Schurer M, Bassler D, Weiser D. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Arzneimittelforschung 2005 55 : 15 22.
24. Braun A, Hammerle S, Suda K, Rothen-Rutishauser B, Gunthert M, Kramer SD, et al. Cell cultures as tools in biopharmacy. Eur J Pharm Sci 2000 11 Suppl 2 : S51 60.
25. Walgren RA, Kamaky KJ Jr., Lindenmayer GE, Walle T. Efflux of dietary flavonoid quercetin 4"-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 2000 294 : 830 6.
26. Xia CQ, Liu N, Yang D, Miwa G, Gan LS. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab Dispos 2005 33 : 637 43.
27. Gant TW, Silverman JA, Thorgeirsson SS. Regulation of P-glyco-protein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res 1992 20 : 2841 6.
28. Lee CH, Bradley G, Zhang JT, Ling V. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 1993 157 : 392 402.
29. Ader P, Block M, Pietzsch S, Wolffram S. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett 2001 162 : 175 80.
30. Crespy V, Morand C, Besson C, Cotelle N, Vezin H, Demigne C, et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 2003 284 : G980 8.
31. Arts IC, Sesink AL, Faassen-Peters M, Hollman PC. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br J Nutr 2004 91 : 841 7.
32. Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant poly-phenols. Biochem Biophys Res Commun 2004 317 : 269 75.
33. Sesink AL, Arts IC, de Boer VC, Breedveld P, Schellens JH, Hollman PC, et al. Breast cancer resistance protein (Bcrpl/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 2005 67 : 1999 2006.
34. Walle T, Browning AM, Steed LL, Reed SG, Walle UK. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 2005 135 : 48 52.
35. Schneider H, Simmering R, Hartmann L, Pforte H, Blaut M. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 2000 89 : 1027 37.
36. O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G. Metabolism of quercetin-7- and quercetin-3-glu-curonides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003 65 : 479 91.
37. Wang Y, Cao J, Zeng S. Establishment of a P-glycoprotein substrate screening model and its preliminary application. World J Gastroenterol 2004 10 : 1365 8.
38. Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, et al. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 2000 395 : 193 201.